Skip to main content
SpringerLink
Log in

Clinical Pharmacokinetics of Non-steroidal Anti-inflammatory Drugs

  • Review Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

The number of non-steroidal anti-inflammatory drugs (NSAIDs) available for clinical use has dramatically increased during the last decade. As a general rule, NSAIDs are well absorbed from the gastrointestinal tract, with the exception of aspirin (and possibly diclofenac, tolfenamic acid and fenbufen) which undergoes presystemic hydrolysis to form salicylic acid. Concomitant administration of NSAIDs with food or antacids may in some cases lead to delayed or even reduced absorption. The NSAIDs are highly bound to plasma proteins (mainly albumin), which limits their body distribution to the extracellular spaces. Apparent volumes of distribution of NSAIDs are, therefore, very low and usually less than 0.2 L/kg. The elimination of these drugs depends largely on hepatic biotransformation; renal excretion of unchanged drug is usually small (< 5% of the dose). Total body clearance is low and for most NSAIDs is less than 200 ml/min.

The effect of age and disease on the disposition of NSAIDs has not been extensively studied. Due to the central role of the liver in the overall elimination of the majority of these compounds, hepatic disease will most likely lead to a significant alteration in their pharmacokinetic behaviour.

NSAIDs have been reported to be involved in numerous pharmacokinetic drug interactions. Aspirin decreases the plasma concentrations of many other NSAIDs, although the clinical significance of this is uncertain. Due to the extremely high plasma protein binding of NSAIDs (around 99% in many cases), competition for the same binding sites on plasma proteins may be at least partly responsible for some interactions of NSAIDs with other highly bound drugs; however, another mechanism such as decreased metabolism or decreased urinary elimination is usually involved as well. The most important interactions with NSAIDs are those involving the oral anticoagulants and oral hypoglycaemic agents, though not all NSAIDs have been found to interact with these drugs.

In clinical practice, there appear to be no clear-cut guidelines to assist the clinician in the selection of the most appropriate drug for an individual patient. The selection of an anti-inflammatory drug should be based on clinical experience, patient convenience (e.g. once or twice daily dosage schedule), side effects and cost. Since a marked interindividual variability exists in the clinical response to a given NSAID, clinicians prescribing these agents may try several of them sequentially until an adequate response is obtained.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aarbakke, J.: Clinical pharmacokinetics of phenylbutazone. Clinical Pharmacokinetics 3: 369–380 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Aarbakke, J.; Bakke, O.M.; Milde, E.J. and Davies, D.S.: Disposition and oxidative metabolism of phenylbutazone in man. European Journal of Clinical Pharmacology 11: 359–366 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Adams, S.S.; Crampton, EX.; Nicholson, J.S. and Risdall, P.C.: Metabolism of flurbiprofen in man. XIIIth International Congress of Rheumatology, Kyoto, Japan (1973).

  • Ali, A.; Kazmi, S. and Plakogiannis, F.M.: High-pressure liquid Chromatographic determination of ibuprofen in plasma. Journal of Pharmaceutical Sciences 70: 944–945 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Alván, G.; Orme, M.; Bertillson, L.; Eksrand, R. and Palmer, L.: Pharmacokinetics of indomethacin. Clinical Pharmacology and Therapeutics 18: 364–373 (1975).

    PubMed  Google Scholar 

  • Alvares, A.P.; Kapelner, S.; Sassa, S. and Kappas, A.: Drug metabolism in normal children and normal adults. Clinical Pharmacology and Therapeutics 18: 179–183 (1975).

    Google Scholar 

  • Andreasen, F.: Protein binding of drugs in plasma from patients with acute renal failure. Acta Pharmacologica et Toxicologica 32: 417–429 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Anttila, M.; Haataja, M. and Kasanen, A.: Pharmacokinetics of naproxen in subjects with normal and impaired renal function. European Journal of Clinical Pharmacology 18: 263–268 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Ayres, J.W.; Weidler, D.J.; Mackichan, J.; Sakmar, E.; Hallmark, M.R.; Lemanowicz, E.F. and Wagner, J.G.: Pharmacokinetics of tolmetin with and without concomitant administration of antacid in man. European Journal of Clinical Pharmacology 12: 421–428 (1977a).

    Article  PubMed  CAS  Google Scholar 

  • Ayres, J.W.; Weidler, D.J.; Sakmar, E. and Wagner, J.G.: Linear and nonlinear assessment of tolmetin pharmacokinetics. Research Communications in Chemical Pathology and Pharmacology 17: 583–593 (1977b).

    PubMed  CAS  Google Scholar 

  • Baber, N.; Halliday, L.D.C.; Van Den Heuvel, W.J.A.; Walker, R.W.; Sibeon, R.; Keenan, J.P.; Littler, T. and Orme, M.: Indomethacin in rheumatoid arthritis: Clinical effects, pharmacokinetics and platelet studies in responders and non-responders. Annals of the Rheumatic Diseases 38: 128–137 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Bachman, F.: Synovial fluid concentrations of Piroxicam; in Boyle (Ed.) Rheumatology in the Eighties; An Advance in Therapy — Piroxicam (Excerpta Medica, Princeton 1980).

    Google Scholar 

  • Balali-Mood, M.; King, I.S. and Prescott, L.F.: Rapid estimation of diflunisal in plasma and urine by high-performance liquid chromatography and a comparison with a fluorometric method. Journal of Chromatography 229: 234–240 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Baragar, F.D. and Smith, T.C.: Drug interaction studies with sodium meclofenamate (Meclomen). Current Therapeutic Research 23: S51–S59 (1978).

    Google Scholar 

  • Bardare, M.; Cislaghi, G.V.; Mandeli, M. and Sereni, F.: Value of monitoring plasma salicylate levels in treating juvenile rheumatoid arthritis. Archives of Disease in Childhood 53: 381–385 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Bayne, W.F.; East, T. and Dye, D.: High-pressure liquid chromatographic method with postcolumn, in-line hydrolysis and fluorometric detection for indomethacin in biological fluids. Journal of Pharmaceutical Sciences 70: 458–459 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Bensen, W.G.; Laskin, CA.; Paton, T.W.; Little, H.A. and Farn, A.G.: Twice-daily dosing of enteric-coated aspirin in patients with rheumatic diseases. Journal of Rheumatology 6: 351–356 (1979).

    PubMed  CAS  Google Scholar 

  • Bhat, R.; Vidyasagar, D.; Fisher, E.; Hastreiter, A.; Ramirez, J.L.; Burns, L. and Evans, M.: Pharmacokinetics of oral and intravenous indomethacin in preterm infants. Developmental Pharmacology and Therapeutics 1: 101–110 (1980).

    PubMed  CAS  Google Scholar 

  • Blaschke, T.F.: Protein binding and kinetics of drugs in liver diseases. Clinical Pharmacokinetics 2: 32–44 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Boobis, S. and Brodie, M.J.: The effects of chronic alcohol ingestion and alcoholic liver disease on drug-protein binding. British Journal of Clinical Pharmacology 4: 629P (1977).

    Article  Google Scholar 

  • Bopp, R.J.; Farid, K.Z. and Nash, J.F.: High-performance liquid chromatographic assay for fenoprofen in human plasma. Journal of Pharmaceutical Sciences 70: 507–509 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Brazier, J.L.; Tamisier, J.N.; Ambert, D. and Bannier, A.: Bioavailability of ketoprofen in man with and without concomitant administration of aluminium phosphate. European Journal of Clinical Pharmacology 19: 305–307 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Breuing, K.H.; Gilfrich, H.J.; Meinertz, T. and Jähnchen, E.: Pharmacokinetics of azapropazone following single oral and intravenous doses. Arzneimittel-Forschung 29: 971–972 (1979).

    PubMed  CAS  Google Scholar 

  • Breuing, K.H.; Gifrich, H.J.; Meinertz, T. and Jåhnchen, E.: Disposition of azapropazone in chronic renal and hepatic failure. European Journal of Clinical Pharmacology 20: 147–155 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Brodie, B.B.; Lowman, E.W.; Burns, J.J.; Lee, P.R.; Chenkin, T.; Goldman, A.; Weiner, M. and Steele, M.J.: Observations on the anti-rheumatic and physiologic effects of phenylbutazone (Butazolidin) and some comparisons with cortisone. American Journal of Medicine 16: 181–190 (1954).

    Article  PubMed  CAS  Google Scholar 

  • Brogden, R.N.; Heel, R.C.; Pakes, G.E.; Speight, T.M. and Avery, G.S.: Diflunisal: A review of its pharmacological properties and therapeutic use in pain in osteoarthritis. Drugs 19: 84–106 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Brogden, R.N.; Heel, R.C.; Speight, T.M. and Avery G.S.: Alclofenac: A review of its pharmacological properties and therapeutic efficacy in rheumatoid arthritis and allied rheumatic disorders. Drugs 14: 241–259 (1977a).

    Article  PubMed  CAS  Google Scholar 

  • Brogden, R.N.; Heel, R.C.; Speight, T.M. and Avery, G.S.: Tolmetin: A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. Drugs 15: 429–450 (1978a).

    Article  PubMed  CAS  Google Scholar 

  • Brogden, R.N.; Heel, R.C.; Speight, T.M. and Avery, G.S.: Sulindac: A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. Drugs 16: 97–114 (1978b).

    Article  PubMed  CAS  Google Scholar 

  • Brogden, R.N.; Heel, R.C.; Speight, T.M. and Avery, G.S.: Flurbiprofen: A review of its pharmacological properties and therapeutic use in rheumatic diseases. Drugs 18: 417–438 (1979a).

    Article  PubMed  CAS  Google Scholar 

  • Brogden, R.N.; Heel, R.C.; Speight, T.M. and Avery, G.S.: Naproxen up to date: A review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states. Drugs 18: 241–277 (1979b).

    Article  PubMed  CAS  Google Scholar 

  • Brogden, R.N.; Heel, R.C.; Speight, T.M. and Avery, G.S.: Piroxicam: A review of its pharmacological properties and therapeutic efficacy. Drugs 22: 165–187 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Brogden, R.N.; Pinder, R.M.; Speight, T.M. and Avery, G.S.: Fenoprofen: A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. Drugs 13: 241–265 (1977b).

    Article  PubMed  CAS  Google Scholar 

  • Brooks, P.M.; Bell, M.A.; Lee, P.; Rooney, P.J. and Dick, W.C: The effect of frusemide on indomethacin plasma levels. Journal of Clinical Pharmacology 1: 485–489 (1974a).

    CAS  Google Scholar 

  • Brooks, P.M.; Bell, M.A.; Sturrock, R.D.; Famaey, J.P. and Dick, W.C: The clinical significance of the indomethacin-probenecid interaction. British Journal of Clinical Pharmacology 1: 287–290 (1974b).

    Article  PubMed  CAS  Google Scholar 

  • Brooks, P.M. and Khong, T.K.: Flurbiprofen-aspirin interaction: A double-blind crossover study. Current Medical Research and Opinion 5: 53–57 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Brooks, P.M.; Walker, J.J.; Dick, W.C; Anderson, J.A. and Fowley, P.D.: Phenylbutazone: A clinicopharmacological study in rheumatoid arthritis. British Journal of Clinical Pharmacology 2: 437–442 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Buchanan, R.N.; Eaton, C.J.; Koffe, S.T. and Kinkel, A.W.: The breast milk excretion of flufenamic acid. Current Therapeutic Research 11: 533–538 (1969).

    PubMed  CAS  Google Scholar 

  • Burns, J.J.; Rose, R.K.; Chenkin, T.; Goldman, A.; Schulert, A. and Brodie, B.: The physiological disposition of phenylbutazone (Butazolidin) in man and a method for its estimation in biological material. Journal of Pharmacology and Experimental Therapeutics 109: 346–357 (1953).

    PubMed  CAS  Google Scholar 

  • Cardoe, N.; de Silva, M.; Glass, R.C. and Risdall, P.C.: Serum concentrations of flurbiprofen in rheumatoid patients receiving flurbiprofen over long periods of time. Current Medical Research and Opinion 5: 21–25 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Cassell, S.; Furst, D.; Dromgoole, S. and Paulus, H.: Steady-state serum salicylate levels in hospitalized patients with rheumatoid arthritis. Arthritis and Rheumatism 22: 384–388 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Chalmers, I.M.; Bell, M.A. and Buchanan, W.W.: Effect of flurbiprofen on the metabolism of antipyrine in man. Annals of the Rheumatic Diseases 32: 58–61 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Chalmers, T.M.; Glass, R.C. and Risdall, P.C.: Concentrations of flurbiprofen in serum and synovial fluid from patients with active rheumatoid disease: Some preliminary observations. Current Medical Research and Opinion 5: 17–20 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Chernish, S.M.; Rubin, A.; Rodda, B.E.; Ridolfo, A.S. and Gruber, C.M. Jr.: The physiological disposition of fenoprofen in man. IV. The effects of position of subject, food ingestion and antacid ingestion on the plasma levels of orally administered fenoprofen. Journal of Medicine (Experimental and Clinical) 3: 249–257 (1972).

    CAS  Google Scholar 

  • Chiccarelli, F.S.; Eisner, H.J. and Van Lear, G.E.: Metabolic and pharmacokinetic studies with fenbufen in man. Arzneimittel-Forschung 30: 728–735 (1980).

    PubMed  CAS  Google Scholar 

  • Chlud, K. and Kaik, B.; Clinical studies of the interaction between tolmetin and glibcnclamide. International Journal of Clinical Pharmacology 15: 409–410 (1977).

    CAS  Google Scholar 

  • Cockel, R.; Kendall, M.J.; Becker, J.F. and Hawkins, C.F.: Serum biochemical values in rheumatoid disease. Annals of the Rheumatic Diseases 30: 166–170 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Cressman, W.A.; Wortham, F. and Plostnieks, J.: Absorption and excretion of tolmetin in man. Clinical Pharmacology and Therapeutics 19: 224–233 (1976).

    PubMed  CAS  Google Scholar 

  • Crook, P.R.; Willis, J.V.; Kendall, M.J.; Jack, D.B. and Fowler, P.D.: The pharmacokinetics of diclofenac sodium in patients with active rheumatoid disease. European Journal of Clinical Pharmacology 21: 331–334 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Cuisinaud, G.; Legheand, J.; Belkahia, C. and Sassard, J.: Gas chromatographic determination of 3-(4-biphenylylcarbonyl) propionic acid (fenbufen) and two metabolites in human plasma. Journal of Chromatography 148: 509–513 (1978).

    PubMed  CAS  Google Scholar 

  • Cuisinaud, G.; Legheand, J.; Llorca, G.; Belkahia, C; Lejeune, E. and Sassard, J.: Pharmacokinetics of fenbufen in man. European Journal of Clinical Pharmacology 16: 59–61 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Cuny, G.; Roger, R.J.; Mur, J.M.; Serot, J.M.; Faure, G.; Netter, P.; Maillard, A. and Perrin, F.: Pharmacokinetics of salicylates in the elderly. Gerontology 25: 49–55 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Davies, E.F. and Avery, G.S.: Ibuprofen: A review of its pharmacological properties and therapeutic efficacy in rheumatic disorders. Drugs 2: 416–446 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Day, R.O.; Furst, D.E.; Dromgoole, S.H.; Kam, B.; Roe, R. and Paulus, H.E.: Relationship of serum naproxen concentration to efficacy in rheumatic arthritis. Clinical Pharmacology and Therapeutics 31: 733–740 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Dayton, P.G.; Israeli, Z.H. and Perel, J.M.: Influence of binding on drug metabolism and distribution. Annals of the New York Academy of Sciences 226: 172–194 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Delbarre, F.; Roucayrol, J.C.; Amor, B.; Ingrand, J.; Bourat, G.; Fournel, J. and Courjaret, J.: Pharmacokinetic study of ketoprofen (19.583 R.P.) in man using tritiated compound. Scandinavian Journal of Rheumatology 14 (Suppl.): 45–52 (1976).

    Google Scholar 

  • Denko, C.W.; Purser, D.B. and Johnson, R.M.: Amino acid composition of serum albumin in normal individuals and in patients with rheumatoid arthritis. Clinical Chemistry 16: 54–57 (1970).

    PubMed  CAS  Google Scholar 

  • Desager, J.P.; Vanderbist, M. and Harvengt, C.: Naproxen plasma levels in volunteers after single-dose administration by oral and rectal routes. Journal of Clinical Pharmacology 16: 189–193 (1976).

    PubMed  CAS  Google Scholar 

  • Dieterle, W.; Faigle, J.W.; Früh, F.; Mory, H.; Theobald, W.; Alt, K.O. and Richter, W.J.: Metabolism of phenylbutazone in man. Arzneimittel-Forschung 26: 572–577 (1976).

    PubMed  CAS  Google Scholar 

  • Doughty, R.A.; Giesecke, L. and Athreya, B.: Prospective study of salicylate therapy in juvenile rheumatoid arthritis: Dosage, serum salicylate levels, and clinical/biochemical toxicity. Clinical Pharmacology and Therapeutics 25: 221 (1979).

    Google Scholar 

  • Dromgoole, S.H. and Furst, D.E.: Salicylates: in Evans et al. (Eds) Applied Pharmacokinetics, pp.486–517 (Applied Therapeutics Inc., San Francisco 1980).

    Google Scholar 

  • Duggan, D.E.; Hare, L.E.; Ditzler. C.A.; Lei, B.W. and Kwan, K.C.: The disposition of sulindac. Clinical Pharmacology and Therapeutics 21: 326–335 (1977).

    PubMed  CAS  Google Scholar 

  • Duggan, D.E.; Hogans, A.F.; Kwan, K.C. and McMahon, F.G.: The metabolism of indomethacin in man. Journal of Pharmacology and Experimental Therapeutics 181: 563–575 (1972).

    PubMed  CAS  Google Scholar 

  • Duggan, D.E.; Hooke, K.F.; Noll, R.M. and Kwan, K.C: Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochemical Pharmacology 25: 1749–1754 (1975).

    Article  Google Scholar 

  • Dunky, A.: Interaction study with digoxin and fenbufen. Presented at the IXth European Rheumatology Congress, Wiesbaden (1979).

  • Dupont, D.; Dayer, P.; Balant, L.; Gorgia, A. and Fabre, J.: Variations interet intraindividuelles du comportement du Piroxicam. Pharmacocinétique chez l’homme en bonne santé et chez le malade en insuffisance rénale. Pharmaceutica Acta Helvetiae 57: 20–26 (1982).

    PubMed  CAS  Google Scholar 

  • Emori, H.W.; Champion, G.D.; Bluestone, R. and Paulus, H.E.: Simultaneous pharmacokinetics of indomethacin in serum and synovial fluid. Annals of Rheumatic Diseases 32: 433–435 (1973).

    Article  CAS  Google Scholar 

  • Emori, H.W.; Paulus, H.E.; Bluestone, R.; Champion, G.D. and Pearson, C.: Indomethacin serum concentrations in man. Effects of dosage, food and antacid. Annals of Rheumatic Diseases 35: 333–338 (1976).

    Article  CAS  Google Scholar 

  • Evans, M.A.; Bhat, R.; Vidyasagar, D.; Vadapalli, M; Fisher, E. and Hastreiter, A.: Gestational age and indomethacin elimination in the neonate. Clinical Pharmacology and Therapeutics 26: 746–751 (1979).

    PubMed  CAS  Google Scholar 

  • Evans, M.A.: GLC microdetermination of indomethacin in plasma. Journal of Pharmaceutical Sciences 69: 219–220 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Farr, M. and Willis, J.V.: Investigation of phenylbutazone in synovial fluid. Journal of International Medical Research 5: 26–29 (1977).

    PubMed  Google Scholar 

  • Fausa, O.: Salicylate-induced hypothrombinemia. A report of four cases. Acta Medica Scandinavica 188: 403–408 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Faust-Tinnefeldt, G.; Feissler, H.E. and Mutschler, E.: Azapropazone Plasmaspiegel unter Begleitmedikation mit einem Antacidum oder Laxans. Arzneimittel-Forschung 27: 2411–2414 (1977).

    PubMed  CAS  Google Scholar 

  • Findlay, J.W.A.; DeAngelis, R.L.; Kearney, M.F.; Welch, R.M. and Findlay, J.M.: Analgesic drugs in breast milk and plasma. Clinical Pharmacology and Therapeutics 29: 625–633 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Fleitman, J.S.; Schulman, S.G. and Petrin, J.H.: High-performance liquid chromatography assay for fenbufen and two serum metabolites. Journal of Chromatography 228: 372–376 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Fowler, P.D.: Diclofenac sodium (Voltarol): Drug interactions and special studies. Rheumatology and Rehabilitation (Suppl. 2): 60–68 (1979a).

    PubMed  Google Scholar 

  • Fowler, P.D.: Voltarol: Diclofenac sodium. Clinics in Rheumatic Diseases 5: 427–464 (1979b).

    Google Scholar 

  • Garnham, J.C.; Kaspi, T.; Kaye, CM. and Oh, V.M.S.: The different effects of sodium bicarbonate and aluminium hydroxide on the absorption of indomethacin in man. Postgraduate Medical Journal 53: 126–129 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Garrettson, L.K.; Procknal, J.A. and Levy, G.: Fetal acquisition and neonatal elimination of a large amount of salicylate. Clinical Pharmacology and Therapeutics 17: 98–103 (1975).

    PubMed  CAS  Google Scholar 

  • Geaney, D.P.; Carver, J.G.; Aronson, J.K. and Warlow, C.P.: Interaction of azapropazone with Phenytoin. British Medical Journal 284: 1373 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Geiger, U.P.; Degen, P.H. and Sioufi, A.: Quantitative assay of diclofenac in biological material by gas-liquid chromatography. Journal of Chromatography 111: 293–298 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Gibaldi, M.; Grundhofer, B. and Levy, G.: Effect of antacids on pH of urine. Clin. Pharmacol. Ther. 16: 520–525 (1974).

    PubMed  CAS  Google Scholar 

  • Gikalov, I.; Kaufmann, R. and Schuster, O.: Humanpharmakokinetic verschiedener i.v. Dosen von Azapropazon (HPLC-Bestimmung). Arzneimittel-Forschung 32: 423–426 (1982).

    PubMed  CAS  Google Scholar 

  • Glass, R.C. and Swannell, A.J.: Concentrations of ibuprofen in serum and synovial fluid from patients with arthritis. British Journal of Clinical Pharmacology 6: 453P–454P (1978).

    Article  Google Scholar 

  • Glazko, A.J.: Pharmacology of the fenamates. III. Metabolic disposition. Annals of Physical Medicine 9: 23–26 (1967).

    Google Scholar 

  • Glazko, A.J.; Chang, T.; Borondy, P.E.; Dill, W.A.; Young, R. and Croskey, L.: Metabolic disposition of meclofenamic acid (Meclomen) in laboratory animals and in man. Current Therapeutic Research 23: 522–541 (1978).

    Google Scholar 

  • Grennan, D.M.; Ferry, D.G.; Ashworth, M.E.; Kenny, R.E. and MacKinnon, M.: The aspirin-ibuprofen interaction in rheumatoid arthritis. British Journal of Clinical Pharmacology 8: 497–503 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Grindel, J.M.; Migdalof, B.H. and Plostnieks, J.: Absorption and excretion of tolmetin in arthritic patients. Clinical Pharmacology and Therapeutics 26: 122–128 (1979).

    PubMed  CAS  Google Scholar 

  • Gugler, R.: The effect of disease on the response to drugs; in Boissier et al. (Eds) Proceedings of the 7th International Congress of Pharmacology, pp.67–76 (Pergamon, Oxford 1979).

    Google Scholar 

  • Hamar, C. and Levy, G.: Factors affecting the serum protein binding of salicylate acid in newborn infants and their mothers. Pediatric Pharmacology 1: 31–43 (1980).

    PubMed  CAS  Google Scholar 

  • Hammer, W.; Mårtens, S. and Sjöqvist, F.: A comparative study of the metabolism of desmethylimipramine, nortriptyline, and oxyphenylbutazone in man. Clinical Pharmacology and Therapeutics 10: 44–49 (1969).

    PubMed  CAS  Google Scholar 

  • Hansen, P.D.: Drug Interactions (Lea and Febiger, Philadelphia 1979).

    Google Scholar 

  • Held, H. and Enderle, C.: Elimination and serum protein binding of phenylbutazone in patients with renal insufficiency. Clinical Nephrology 6: 388–393 (1976).

    PubMed  CAS  Google Scholar 

  • Helleberg, L.: Clinical pharmacokinetics of indomethacin. Clinical Pharmacokinetics 6: 245–258 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Helleberg, L.; Rubin, A.; Wolen, R.L.; Rodda, B.E.; Ridolfo, A.S. and Gruber, C.M. Jr.: A pharmacokinetic interaction in man between phenobarbitone and fenoprofen, a new anti-inflammatory agent. British Journal of Clinical Pharmacology 1: 371–374 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Henson, R.; Lloyd-Jones, J.G.; Nichols, J.D. and Jordan, B.J.: Pharmacokinetics of fenclofenac following single and multiple doses. European Journal of Drug Metabolism and Pharmacokinetics 5: 217–223 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Higham, C.; Aarons, L.; Holt, P.J.L.; Lynch, M. and Rowland, M.: A chronic dose-ranging study of the pharmacokinetics of phenylbutazone in rheumatoid arthritis patients. British Journal of Clinical Pharmacology 12: 123–129 (1981).

    PubMed  CAS  Google Scholar 

  • Hobbs, D.C. and Twomey, T.M.: Piroxicam pharmacokinetics in man: Aspirin and antacid interaction studies. Journal of Clinical Pharmacology 19: 270–281 (1979).

    PubMed  CAS  Google Scholar 

  • Holmes, E.L.: Pharmacology of the fenamates. IV. Toleration by normal human subjects. Annals of Physical Medicine 9 (Suppl.): 36–49 (1967).

    Google Scholar 

  • Hucker, H.B.; Stauffer, S.C.; White, S.D.; Rhodes, R.A.; Arrison, B.H.; Umbenhauer, E.R.; Bower. R.J. and McMahon, F.G.: Physiologic disposition and metabolic fate of a new anti-inflammatory agent cis-5-fluoro-2-methyl-1-[p-(methylsulfinyl)-benzylide-nyl]-idene-3-acetic acid in the rat, dog, rhesus monkey, and man. Drug Metabolism and Disposition 1: 721–736 (1973).

    PubMed  CAS  Google Scholar 

  • Huskisson, E.C.; Woolf, G.L.; Balme, H.W.; Scott, J. and Franklyn, S.: Four anti-inflammatory drugs: Responses and variations. British Medical Journal 1: 1048–1049 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Hvidberg, E.F.; Andreasen, P.B. and Ranek, L.: Plasma half-life of phenylbutazone in patients with impaired liver function. Clinical Pharmacology and Therapeutics 15: 171–177 (1974).

    PubMed  CAS  Google Scholar 

  • Ikeda, M.; Kawase, M.; Hiramatsu, M.; Hirota, K. and Ohmori, S.: Improved gas chromatographic method of determining diclofenac in plasma. J. Chromatog. 183: 41–47 (1980).

    Article  CAS  Google Scholar 

  • Ishizaki, T.; Nomura, T. and Abe, T.: Pharmacokinetics of piroxicam, a new non-steroidal anti-inflammatory agent, under fasting and postprandial states in man. Journal of Pharmacokinetics and Biopharmaceutics 7: 369–381 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Ishizaki, T.; Sasaki, T.; Suganuma, T.; Horai, Y.; Chiba, K.; Watanabe, M.; Asuke, W. and Hoshi, H.: Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration. European Journal of Clinical Pharmacology 18: 407–414 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Jähnchen, E.; Blanck, K.J.; Breuing, K.H.; Gilfrich, H.J.; Meiniertz, T. and Trenk, D.: Plasma protein binding of azapropazone in patients with kidney and liver disease. British Journal of Clinical Pharmacology 11: 361–367 (1981).

    Article  PubMed  Google Scholar 

  • Jain, A.; McMahar, F.G.; Slattery, J.T. and Levy, G.: Effect of naproxen on steady-state serum concentration and anticoagulant activity of warfarin. Clinical Pharmacology and Therapeutics 25: 61–66(1979).

    PubMed  CAS  Google Scholar 

  • Jalava, S.; Saarimaa, H.; Anttila, M. and Sundquist, H.: Naproxen concentrations in serum synovial fluid, and synovium. Scandinavian Journal of Rheumatology 6: 155–157 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Jeremy, R. and Towson, J.: Interaction of aspirin and indomethacin in the treatment of rheumatoid arthritis. Medical Journal of Australia 2: 127–129 (1970).

    PubMed  CAS  Google Scholar 

  • Kaiser, D.G.; Shaw, S.R. and Vangiessen, G.J.: GLC determination of dl-2(2-fluoro-4-biphenylyl) propionic acid (flurbiprofen) in plasma. Journal of Pharmaceutical Sciences 63: 567–570 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Kampmann, J.; Hansen, J.M.; Siersback-Nielsen, K. and Laursen, H.: Effect of some drugs on penicillin half-life in blood. Clinical Pharmacology and Therapeutics 13: 516–519 (1972).

    PubMed  CAS  Google Scholar 

  • Kaneo, Y.; Kai, A.; Kiryu, S. and Iguchi, S.: Protein binding of non-steroidal anti-inflammatory agents. I. Journal of Pharmaceutical Society of Japan 96: 1412–1416 (1976).

    CAS  Google Scholar 

  • Kaniwa, N.; Ogata, H.; Aoyagi, N. and Ejima, A.: The bioavailability of flufenamic acid from aluminium flufenamate tablet and flufenamic acid capsule, and the influence of food and aluminium hydroxide gel. Journal of Pharmacobio-Dynamics 5: 187–192 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Kantor, G.T.: Ibuprofen. Annals of Internal Medicine 91: 877–882 (1979).

    PubMed  CAS  Google Scholar 

  • Kauffmann, R.E.; Bolliger, R.O.; Wan, S.H. and Oren, J.: Pharmacokinetics and metabolism of naproxen in children. Developmental Pharmacology and Therapeutics 5: 143–150 (1982).

    PubMed  CAS  Google Scholar 

  • Kaye, C.M.; Sankey, M.G. and Holt, J.E.: A high-pressure liquid chromatographic method for the assay of ketoprofen in plasma and urine, and its application to determining the urinary excretion of free and conjugated ketoprofen following oral administration of Orudis® to man. British Journal of Clinical Pharmacology 11: 395–398 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Klinenberg, J.R. and Miller, F.: Effect of corticosteroids on blood salicylate concentrations. Journal of the American Medical Association 194: 601–604 (1965).

    Article  PubMed  CAS  Google Scholar 

  • Kozma, C. and Daffner, R.: Pharmacokinetics of flurbiprofen taken fasting and after food. Abstract of paper presented at the 9th European Congress of Rheumatology, Wiesbaden (1979).

  • Krzywanek, H.J. and Breddin, K.: Beeinflusst Diclofenac die orale Amikoagulantienstherapie und die Plaettchenaggregation. Medizinische Welt 28: 1843–1845 (1977).

    PubMed  CAS  Google Scholar 

  • Kunze, M.; Stein, G.; Kunze, E. and Traeger, A.: Zur Pharmakokinetik von Indomethazin in Abhaengigkeit von Lebensalter, bei Patienten mit Gallenwegsverschluss, Nierenfunktionseinschrankung und Unvertraglichkeitserscheinungen. Deutsche Gesundheitswesen 29: 351–353 (1974).

    Google Scholar 

  • Kwan, K.C.; Breault, G.O.; Umbenhauer, E.R.; McMahon, F.G. and Duggan, D.E.: Kinetics of indomethacin absorption, elimination and enterohepatic circulation in man. Journal of Pharmacokinetics and Biopharmaceutics 4: 255–280 (1975).

    Google Scholar 

  • Kwan, K.C.; Breault, G.O.; Davis, R.L.; Lei, B.W.; Czerwinski, A.W.; Besselaar, G.H. and Duggan, D.E.: Effects of concomitant aspirin administration on the pharmacokinetics of indomethacin in man. Journal of Pharmacokinetics and Biopharmaceutics 6: 451–476 (1978a).

    Article  PubMed  CAS  Google Scholar 

  • Kwan, K.C.; Duggan, D.; Van Arman, CG. and Shen, T.Y.: Sulindac: Chemistry, pharmacology and pharmacokinetics. European Journal of Rheumatology and Inflammation 1: 9–11 (1978b).

    Google Scholar 

  • Leber, H.W.; Harders, A. and Schütterle, G.: Untersuchungen zum Einfluss der Urämie auf die Metabolisierung von Phenylbutazon und Aminophenazon beim Menschen. Klinische Wochenschrift 50: 1092–1096 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Lee, P.; Anderson, J.A.; Miller, J.; Webb, J. and Buchanan, W.W.: Evaluation of analgesic action and efficacy of antirheumatic drugs. Study of 10 drugs in 684 patients with rheumatoid arthritis. Journal of Rheumatology 3: 283–294 (1976).

    PubMed  CAS  Google Scholar 

  • Levi, J.; Sherlock, S. and Walker, D.: Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet 1: 1275–1279 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Levy, G.: Pharmacokinetics of salicylate in man. Drug Metabolism Reviews 9: 3–19 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Levy, G.: Clinical pharmacokinetics of salicylates: A re-assessment. British Journal of Clinical Pharmacology 10: 2855–2905 (1980).

    Google Scholar 

  • Levy, G. and Garrettson, L.K.: Kinetics of salicylate elimination by newborn infants of mothers who ingested aspirin before delivery. Pediatrics 53: 201–210 (1974).

    PubMed  CAS  Google Scholar 

  • Levy, G. and Giacomini, K.M.: Rational aspirin dosage regimens. Clinical Pharmacology and Therapeutics 23: 247–252 (1978).

    PubMed  CAS  Google Scholar 

  • Levy, G.; Gumtow, R.H and Rutowski, J.M.: The effect of dosage form upon the gastrointestinal absorption rate of salicylate. Canadian Medical Association Journal 85: 414–419 (1961).

    PubMed  CAS  Google Scholar 

  • Levy, G.; Procknal, J.A.; Olufs, R. and Pachman, L.M.: Relationship between saliva salicylate concentration and free or total salicylate concentation in serum of children with juvenile rheumatoid arthritis. Clinical Pharmacology and Therapeutics 27: 619–627 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Levy, G. and Tsuchiya, T.: Salicylate accumulation kinetics in man. New England Journal of Medicine 287: 430–432 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Levy, G.; Vogel, A.W. and Amsel, L.P.: Capacity limited salicylurate formation during prolonged administration of aspirin to healthy human subjects. Journal of Pharmaceutical Sciences 58: 503–504 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Lewellen, O.R.W. and Templeton, R.: The pharmacokinetics of ketoprofen in man during and after repeated oral dosing (50mg q.i.d.) with Orudis. Scandinavian Journal of Rheumatology 14(Suppl.): 53–62(1976).

    Google Scholar 

  • Lewis, R.J.; Trager, W.F.; Chan, K.K.; Breckenridge, A.; Orme, M.; Rowland, M. and Schary, W.: Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone. Journal of Clinical Investigation 53: 1607–1617 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Liegler, D.G.; Henderson, E.S.; Hahn, M.A. and Oliverio, V.T.: The effect of organic acids on renal clearance of methotrexate in man. Clinical Pharmacology and Therapeutics 10: 849–857 (1969).

    PubMed  CAS  Google Scholar 

  • Lin. C.K.; Lee, C.S. and Perrin, J.H.: Determination of two fenamates in plasma by high-performance liquid chromatography. Journal of Pharmaceutical Sciences 69: 95–97 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Lowenthal, D.T.; Briggs, W.A. and Levy, G.: Kinetics of salicylate elimination by anephric patients. Journal of Clinical Investigation 54: 1221–1226 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Mäkelä, A.-L.: Naproxen in the treatment of juvenile rheumatoid arthritis. Metabolism, safety, and efficacy. Scandinavian Journal of Rheumatology 6: 193–205 (1977).

    Article  PubMed  Google Scholar 

  • Mäkelä. A.-L.; Yrjänä. T. and Mattila, M.: Dosage of salicylates for children with juvenile rheumatoid arthritis. Acta Paediatrica Scandinavica 68: 423–430 (1979).

    Article  PubMed  Google Scholar 

  • Marbet, G.A.; Duckert. F.; Walter, M.; Six, P. and Airenne, H.: Interaction study between phenprocoumon and flurbiprofen. Current Medical Research and Opinion 5: 26–31 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Marunaka, T.; Shibata, T.; Minamt, Y. and Umeno, Y.: Simultaneous determination of phenylbutazone and its metabolites in plasma and urine by high-performance liquid chromatography. Journal of Chromatography 183: 331–338 (1980).

    Article  PubMed  CAS  Google Scholar 

  • McElnay, J.C. and D’Arcy, P.F.: Interaction between azapropazone and warfarin. British Medical Journal 2: 773–774 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Meacock, S.C.R. and Kitchen, E.A.: Effects of the non-steroidal anti-inflammatory drug benoxaprofen on leucocyte migration. Journal of Pharmacy and Pharmacology 31: 366–370 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Michot, F.; Ajdacic, K. and Glaus, L.: A double blind clinical trial to determine if an interaction exists between diclofenac sodium and the oral anti-coagulant acenocoumarol (nicoumalone). Journal of International Medical Research 3: 153–157 (1975).

    PubMed  CAS  Google Scholar 

  • Miller, D.R.: Combination use of nonsteroidal anti-inflammatory drugs. Drug Intelligence and Clinical Pharmacy 15: 3–7 (1981).

    PubMed  CAS  Google Scholar 

  • Moncada, S. and Vane, J.R.: Model of action of aspirin-like drugs. Advances in Internal Medicine 24: 1–22 (1979).

    PubMed  CAS  Google Scholar 

  • Montgomery, P.R. and Sitar, D.S.: Increased serum salicylate metabolites with age in patients receiving chronic acetylsalicylic acid therapy. Gerontology 27: 329–333 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Müller, F.O.; Hundt, H.K.L. and Müller, D.G.: Pharmacokinetic and pharmacodynamic implications of long-term administration of non-steroidal anti-inflammatory agents. International Journal of Clinical Pharmacology 15: 397–402 (1977).

    Google Scholar 

  • Mussche, M.M.; Belpaire, F.M. and Bogaert, M.G.: Plasma protein binding of phenylbutazone during recovery from acute renal failure. European Journal of Clinical Pharmacology 9: 69–71 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Nielsen-Kudsk, F.: HPLC-determination of some antiinflammatory weak analgesic and uricosuric drugs in human blood plasma and its application to pharmacokinetics. Acta Pharmacologica et Toxicologica 47: 267–273 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Øie, S. and Levy, G.: Interindividual differences in the effect of drugs on bilirubin plasma binding in newborn infants and in adults. Clinical Pharmacology and Therapeutics 21: 627–632 (1977).

    PubMed  Google Scholar 

  • O’Malley. I.; Crooks, J.; Duke, E. and Stevenson, I.H.: Effect of age and sex on human drug metabolism. British Medical Journal 3: 607–609 (1971).

    Article  PubMed  Google Scholar 

  • O’Reilly, R.A.; Sahud, M.A. and Aggeler, P.M.: Impact of aspirin and chlorthalidone on the pharmacodynamics of oral anticoagulant drugs in man. Annals of the New York Academy of Sciences 179: 173–186 (1971).

    Article  PubMed  Google Scholar 

  • Pachman, L.M.; Olufs, R.; Procknal, J.A. and Levy, G.: Pharmacokinetic monitoring of salicylate therapy in children with juvenile rheumatoid arthritis. Arthritis and Rheumatism 22: 826–831 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Paulus, H.E.; Siegel, M.; Mongan, E.; Okun, R. and Calabro, J.J.: Variations of serum concentrations and half-life of salicylate in patients with rheumatoid arthritis. Arthritis and Rheumatism 14: 527–532 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Penner, J.A. and Abbrecht. P.H.: Lack of interaction between ibuprofen and warfarin. Current Therapeutic Research 18: 862–871 (1975).

    PubMed  CAS  Google Scholar 

  • Pentikäinen, P.J.; Neuvonen, P.J. and Backman, C.: Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent. European Journal of Clinical Pharmacology 19: 359–365 (1981).

    Article  PubMed  Google Scholar 

  • Pentikäinen, P.J.; Neuvonen, P.J.; Penttila, A. and Backman, C.: Pharmacokinetics of tolfenamic acid. Abstracts, World Conference on Clinical Pharmacology and Therapeutics, London (1980).

    Google Scholar 

  • Pond, S.M.; Birkett, D.J. and Wade, D.N.: Mechanisms of inhibition of tolbutamide metabolism: Phenylbutazone, oxyphenbutazone, sulfaphenazole. Clinical Pharmacology and Therapeutics 22: 573–579 (1978).

    Google Scholar 

  • Powell-Jackson, P.R.: Interaction between azapropazone and warfarin. British Medical Journal 1: 1193–1194 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Rawles, J.M.: Antagonism between non-steroidal anti-inflammatory drugs and diuretics. Scottish Medical Journal 27: 37–40 (1982).

    PubMed  CAS  Google Scholar 

  • Reimann, I.W. and Frölich, J.C.: Effects of diclofenac on lithium kinetics. Clinical Pharmacology and Therapeutics 30: 348–353 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Riess, W.; Stierlin, H.; Degen, P.; Faigle, J.W.; Gerardin, A.; Moppert, J.; Sallman, A.; Schmid, K.; Schweizer, A.; Sulc, M.; Theobald, W. and Wagner, J.: Pharmacokinetics and metabolism of the anti-inflammatory agent Voltaren. Scandinavian Journal of Rheumatology (Suppl. 22): 17–29 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Risdall, P.C.; Adams, S.S.; Crampton, E.L. and Marchant, B.: The disposition and metabolism of flurbiprofen in several species including man. Xenobiotica 8: 691–704 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Ritch, A.E.S.; Perera, W.N.R. and Jones, C.J.: Pharmacokinetics of azapropazone in the elderly. British Journal of Clinical Pharmacology 14: 116–119 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Robinson, R.G. and Radcliff, F.J.: The effect of meclofenamic acid on plasma uric acid levels. Medical Journal of Australia 1: 1079–1080 (1972).

    PubMed  CAS  Google Scholar 

  • Rogers, H.J.; Savitsky, J.P.; Glenn, B. and Spector, R.G.: Kinetics of single doses of fenbufen in patients with renal insufficiency. Clinical Pharmacology and Therapeutics 29: 74–80 (1981)

    Article  PubMed  CAS  Google Scholar 

  • Roncucci, R.; Simon, M.-J.; Lambelin, G.; Gillet, G.; Staquet, M. and Buu-Hoi, N.: Metabolic patterns of 4-allyloxy-3-chlorophenyl acetic acid in rat, rabbit, dog, monkey and man. Arzneimittel-Forschung 20: 631–636 (1970).

    PubMed  CAS  Google Scholar 

  • Roncucci, R.; Simon, M.-J.; Lambelin, G.; Staquet, M.; Gillet, C.; Van Cauwenberge, H.; Lefebvre, P.; Daubresse, J.C. and Buu-Hoi, N.P.: Kinetic studies on the absorption and excretion of 4-allyloxy-3-chlor-phenylacetic acid (alclofenac) in man. European Journal of Clinical Pharmacology 3: 176–183 (1971).

    Article  Google Scholar 

  • Rowland, M.; Riegelman, S.; Harris, P.A.; Sholkoff, S.D. and Eyring, E.J.: Kinetics of acetylsalicylic acid disposition in man. Nature 215; 413–414 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Rowland, M.; Riegelman, S.; Harris, P.A. and Sholkoff, S.D.: Absorption kinetics of aspirin in man following oral administration of an aqueous solution. Journal of Pharmaceutical Sciences 61: 379–385 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Rubin, A.; Chernish, S.M.; Crabtree, R.; Gruber, C.M. Jr.; Helleberg, L.; Rodda, B.E.; Warrick, P.; Wolen, R.L. and Ridolfo, A.S.: A profile of the physiological disposition and gastrointestinal effects of fenoprofen in man. Current Medical Research and Opinion 2: 529–544 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Rubin, A.; Rodda, B.E.; Warrick, P.; Ridolfo, A.S. and Gruber, C.M. Jr.: Physiological disposition of fenoprofen in man. I. Pharmacokinetic comparison of calcium and sodium salts administered orally. Journal of Pharmaceutical Sciences 60: 1797–1801 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Rubin, A.; Rodda, B.E.; Warrick, P.; Ridolfo, A.S. and Gruber, C.M. Jr.: Physiological disposition of fenoprofen in man. II. Plasma and urine pharmacokinetics after oral and intravenous administration. Journal of Pharmaceutical Sciences 61: 739–745 (1972a).

    Article  PubMed  CAS  Google Scholar 

  • Rubin, A.; Rodda, B.E.; Warrick, P.; Gruber, C.M. Jr. and Ridolfo, A.S.: Interactions of aspirin with nonsteroidal antiinflammatory drugs in man. Arthritis and Rheumatism 16: 635–645 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Rubin, A.; Warrick, P.; Wolen, R.L.; Chernish, S.M.; Ridolfo, A.S. and Gruber, C.M.: Physiological disposition of fenoprofen in man. III. Metabolism and protein binding of fenoprofen. Journal of Pharmacology and Experimental Therapeutics 183: 449–457 (1972b).

    PubMed  CAS  Google Scholar 

  • Rubin, A.; Warrick, P.; Wolen, R.L.; Ridolfo, A.S. and Gruber, CM.: The metabolism of fenoprofen in man. Clinical Pharmacology and Therapeutics 13: 151 (1972c).

    Google Scholar 

  • Rumble, R.H. and Roberts, M.S.: Determination of aspirin and its major metabolities in plasma by high-performance liquid chromatography without solvent extraction. Journal of Chromatography 225: 252–260 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Runkel, R.A.; Chaplin, M.; Boost, C.; Segre, E. and Forchielli, E.: Absorption, distribution, metabolism and excretion of naproxen in various laboratory animals and human subjects. Journal of Pharmaceutical Sciences 61: 703–708 (1972a).

    Article  PubMed  CAS  Google Scholar 

  • Runkel, R.; Chaplin, M.D.; Sevelius, H.; Ortega, E. and Segre, E.: Pharmacokinetics of naproxen overdose. Clinical Pharmacology and Therapeutics 20: 269–277 (1976).

    PubMed  CAS  Google Scholar 

  • Runkel, R.; Forchielli, E.; Boost, G.; Chaplin, M.; Hill, R.; Sevelius, H.; Thompson, G. and Segre, E.: Naproxen metabolism, excretion and comparative pharmacokinetics. Scandinavian Journal of Rheumatology (Suppl. 2): 29–36 (1973).

    Article  Google Scholar 

  • Runkel, R.A.; Forchielli, E.; Sevelius, H.; Chaplin, M. and Segre, E.: Nonlinear plasma level response to high doses of naproxen. Clinical Pharmacology and Therapeutics 15: 261–266 (1974).

    PubMed  CAS  Google Scholar 

  • Runkel, R.A.; Kraft, K.S.; Boost, G.; Sevelius, H.; Forchielli, E.; Hill, R.; Mogoun, R.; Szakacs, J.B. and Segre, E.: Naproxen oral absorption characteristics. Chemical and Pharmaceutical Bulletin 20: 1457–1466 (1972b).

    Article  CAS  Google Scholar 

  • Runkel, R.; Mroszczak, E.; Chaplin, M.; Sevelius, H. and Segre, E.: Naproxen-probenecid interaction. Clinical Pharmacology and Therapeutics 24: 706–713 (1978).

    PubMed  CAS  Google Scholar 

  • Rust, O.; Biland, L.; Thilo, D.; Nyman, D. and Duckert, F.: Testing of the anti-rheumatic drug tolmetin for interaction with oral anticoagulants. Schweizerische Medizinische Wochenschrift 105: 752–753 (1975).

    PubMed  CAS  Google Scholar 

  • Ryan, J.R.; Jain, A.K.; McMahon, F.G. and Vargas, R.: On the question of an interaction between sulindac and tolbutamide in the control of diabetes. Clinical Pharmacology and Therapeutics 21: 231–233 (1977).

    PubMed  CAS  Google Scholar 

  • Savitsky, J.P.; Terzakis, T.; Bina, P.; Chiccarelli, F. and Haynes, J.: Fenbufen-warfarin interaction in healthy volunteers. Clinical Pharmacology and Therapeutics 27: 284 (1980).

    Google Scholar 

  • Schiantarelli, P.; Acerbi, D. and Bovis, G.: Some pharmacokinetic properties and bioavailability by oral and rectal route of piroxicam in rodents and in man. Arzneimittel-Forschung 31: 92–97 (1981).

    PubMed  CAS  Google Scholar 

  • Segre, E.: Drug interactions with naproxen. European Journal of Rheumatology and Inflammation 2: 12–18 (1979).

    CAS  Google Scholar 

  • Segre, E.J.; Chaplin, M.; Forchielli, E.; Runkel, R. and Sevelius, H.: Naproxen-aspirin interactions in man. Clinical Pharmacology and Therapeutics 15: 374–379 (1974a).

    PubMed  CAS  Google Scholar 

  • Segre, E.J.; Sevelius, H. and Varady, J.: Effects of antacids on naproxen absorption. New England Journal of Medicine 291: 582–583 (1974b).

    PubMed  CAS  Google Scholar 

  • Sellers, E.M. and Koch-Weser, J.: Displacement of warfarin from human albumin by diazoxide and ethacrynic, mefenamic and nalidixic acids. Clinical Pharmacology and Therapeutics 11: 524–529 (1970).

    PubMed  CAS  Google Scholar 

  • Selley, M.L.; Glass, J.; Triggs, E.J. and Thomas, J.: Pharmacokinetic studies of tolmetin in man. Clinical Pharmacology and Therapeutics 17: 599–605 (1975).

    PubMed  CAS  Google Scholar 

  • Selley, M.L.; Madsen, B.W. and Thomas, J.: Protein binding of tolmetin. Clinical Pharmacology and Therapeutics 24: 694–705 (1978).

    PubMed  CAS  Google Scholar 

  • Selley, M.L.; Thomas, J. and Triggs, E.J.: A gas-liquid chromatographic method for the quantitative determination of tolmetin in plasma and tolmetin and its major metabolite in urine. Journal of Chromatography 94: 143–149 (1974).

    Article  CAS  Google Scholar 

  • Sennello, L.T.; Chu, S.-Y. and Borcherding, J.W.: Gas chromatographic method for the determination of alclofenac in plasma and urine. Journal of Chromatography 147: 485–490 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Serlin, M.J.; Mossman, S.; Sibeon, R.G.; Tempera, K.F. and Breckenridge, A.M.: Interaction between diflunisal and warfarin. Clinical Pharmacology and Therapeutics 28: 493–498 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Sevelius, H.; Runkel, R.; Pardo, A.; Ortega, E.; Varady, J. and Segre, E.: Naproxen suppository: Tissue response and comparative bioavailability. European Journal of Clinical Pharmacology 6: 22–25 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Shimek, J.L.; Rao, N.G.S. and Khalil, S.K.W.: High performance liquid chromatographic analysis of tolmetin, indomethacin and sulindac in plasma. Journal of Liquid Chromatography 4: 1987–2013 (1981a).

    Article  CAS  Google Scholar 

  • Shimek, J.L.; Rao, N.G.S. and Khalil, S.K.: High-pressure liquid chromatographic determination of ibuprofen in plasma. Journal of Pharmaceutical Sciences 70: 514–516 (1981b).

    Article  PubMed  CAS  Google Scholar 

  • Sioufi, A.; Caudal, F. and Marfil, F.: GLC determination of phenylbutazone in human plasma. Journal of Pharmaceutical Sciences 67: 243–245 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Sioufi, A.; Colussi, D.; Caudal, F.; Schoeller, J.P. and Massias, P.: Pharmacokinetics of phenylbutazone in healthy subjects after oral administration of single and multiple doses. Journal of Pharmaceutical Sciences 69: 1413–1416 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Skeith, M.D.; Simkin, P.A. and Healey, L.A.: The renal excretion of indomethacin and its inhibition by probenecid. Clinical Pharmacology and Therapeutics 9: 89–93 (1968).

    PubMed  CAS  Google Scholar 

  • Slattery, J.T.; Levy, G.; Jain, A. and McMahon, F.G.: Effect of naproxen on the kinetics of elimination and anticoagulant activity of a single dose of warfarin. Clinical Pharmacology and Therapeutics 25: 51–60 (1979).

    PubMed  CAS  Google Scholar 

  • Smith, G.L.; Goulbourn, R.A.; Burt, R.A.P. and Chatfield, D.H.: Preliminary studies of absorption and excretion of benoxaprofen in man. British Journal of Clinical Pharmacology 4: 585–590 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Snider, B.G.; Beaubien, L.J.; Sears, D.J. and Rahn, P.D.: Determination of flurbiprofen and ibuprofen in dog serum with automated sample preparation. Journal of Pharmaceutical Sciences 70: 1347–1349 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Soren, A.: Kinetics of salicylates in blood and joint fluid. Journal of Clinical Pharmacology 15: 173–177 (1975a).

    PubMed  CAS  Google Scholar 

  • Soren, A.: Transport time for salicylates from blood to joint fluid — a test of histopathology of the synovial membrane. Journal of Rheumatology 34: 213–220 (1975b).

    CAS  Google Scholar 

  • Soren, A.: Kinetics of salicylates in blood and joint fluid. European Journal of Clinical Pharmacology 16: 279–285 (1979).

    Article  Google Scholar 

  • Steelman, S.L.; Cirillo, V.J. and Tempero, K.F.: The chemistry, pharmacology and clinical pharmacology of diflunisal. Current Medical Research and Opinion 5: 506–514 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Stein, G.; Kunze, M.; Zaumseil, J. and Traeger, A.: Pharmacokinetics of indomethacin and metabolites of indomethacin continuously applied in patients with healthy and damaged kidneys. International Journal of Clinical Pharmacology and Biopharmacy 15: 470–473 (1977).

    PubMed  CAS  Google Scholar 

  • Stierlin, H.; Faigle, J.W. and Colombi, A.: Pharmacokinetics of diclofenac sodium (Voltaren) and metabolites in patients with impaired renal function. Scandinavian Journal of Rheumatology (Suppl. 22): 30–35 (1978).

    Article  PubMed  Google Scholar 

  • Stierlin, H.; Faigle, J.W.; Sallman, A.; Küng, W.; Richter, W.J.; Kriemler, H.-P.; Alt, K.O. and Winkler, T.: Biotransformation of diclofenac sodium (Voltaren) in animals and in man. I. Isolation and identification of principal metabolites. Xenobiotica 9: 601–610 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Stowers, J.M.; Constable, L.W. and Hunter, R.B.: Clinical and pharmacological comparison of chlorpropamide and other sulfonylureas. Annals of the New York Academy of Sciences 74: 689–695 (1959).

    Article  PubMed  CAS  Google Scholar 

  • Sumner, D.D.; Dayton, P.G.; Cucinell, S.A. and Plostnieks, J.: Metabolism of tolmetin in rat, monkey and man. Drug Metabolism and Disposition 3: 283–286 (1975).

    PubMed  CAS  Google Scholar 

  • Takyi, B.E.: Excretion of drugs in human milk. Journal of Hospital Pharmacy 28: 317–325 (1970).

    Google Scholar 

  • Thomas, G.M.; Rees, P.; Dippy, J.E. and Maddock, J.: Simultaneous pharmacokinetics of alclofenac in plasma and synovial fluid in patients with rheumatoid arthritis. Current Medical Research and Opinion 3: 264–267 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Tobert, J.A.; De Schepper, P.; Tjandramaga, T.B.; Mullie, A.; Buntinx, A.P.; Meisinger, M.A.P.; Huber, P.B.; Hall, T.P.P. and Yeh, K.C.: Effect of antacids on the bioavailability of diflunisal in the fasting and postprandial states. Clinical Pharmacology and Therapeutics 30: 385–389 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Tocco, D.J.; Breault, G.O.; Zacchei, A.G.; Steelman, S.L. and Perrier, C.V.: Physiological disposition and metabolism of 5-(2′,4′-difluorophenyl) salicylic acid, a new salicylate. Drug Metabolism and Disposition 3: 453–466 (1975).

    PubMed  CAS  Google Scholar 

  • Traeger, A.; Stein, G.; Kuntze, M. and Zaumseil, G.: Zur Pharmakokinetik von Indomethazin bei nierengeschädigten Patienten. International Journal of Clinical Pharmacology 6: 237–242 (1972).

    CAS  Google Scholar 

  • Triggs, E.J.; Nation, R.L.; Long, A. and Ashley, J.J.: Pharmacokinetics in the elderly. European Journal of Clinical Pharmacology 8: 55–62 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Turakka, H. and Airaksinen, M.M.: Biopharmaceutical assessment of phenylbutazone and indomethacin preparations. Annals of Clinical Research 6 (Suppl. 11): 34–41 (1974).

    PubMed  CAS  Google Scholar 

  • Twomey, T.M.; Bartolucci, S.R. and Hobbs, D.C.: Analysis of Piroxicam in plasma by high-performance liquid chromatography. Journal of Chromatography 183: 104–108 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Twomey, T.M. and Hobbs, D.C.: Biotransformation of Piroxicam by man. Federation Proceedings 37: 271 (1978).

    Google Scholar 

  • Upton, R.A.; Buskin, J.N.; Guentert, T.W.; Williams, R.L. and Riegelman, S.: Convenient and sensitive liquid chromatography assay for ketoprofen, naproxen and other allied drugs in plasma or urine. Journal of Chromatography 190: 119–128 (1980a).

    Article  PubMed  CAS  Google Scholar 

  • Upton, R.A.; Buskin, J.N.; Williams, R.L.; Holford, N.H.G. and Riegelman, S.: Negligible excretion of unchanged ketoprofen, naproxen and probenecid in urine. Journal of Pharmaceutical Sciences 69: 1254–1257 (1980b).

    Article  PubMed  CAS  Google Scholar 

  • Upton, R.A.; Williams, R.L.; Buskin, J.N. and Jones, R.M.: Effects of probenecid on ketoprofen kinetics. Clinical Pharmacology and Therapeutics 31: 705–712 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Upton, R.A.; Williams, R.L.; Guentert, T.W.; Buskin, J.N. and Riegelman, S.: Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay. European Journal of Clinical Pharmacology 20: 127–133 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Van Loenhout, J.W.A.; Ketelaars, H.C.J.; Gribnau, F.W.J.; Van Ginneken, C.A.M. and Tan, Y.: Rapid high-performance liquid chromatographic method for the quantitative determination of diflunisal in plasma. Journal of Chromatography 182: 487–491 (1980).

    Article  PubMed  Google Scholar 

  • Verbeeck, R.K.: Glucuronidation and disposition of drug glucuronides in patients with renal failure. Drug Metabolism and Disposition 10: 87–89 (1982).

    PubMed  CAS  Google Scholar 

  • Verbeeck, R.K.; Boel, A.; Buntinx, A. and De Schepper, P.J.: Plasma protein binding and interaction studies with diflunisal, a new salicylate analgesic. Biochemical Pharmacology 29: 571–576 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Verbeeck, R.K.; Branch, R.A. and Wilkinson, G.R.: Drug metabolites in renal failure: Pharmacokinetic and clinical implications. Clinical Pharmacokinetics 6: 329–345 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Verbeeck, R.K. and De Schepper, P.J.: Influence of chronic renal failure and hemodialysis on diflunisal plasma protein binding. Clinical Pharmacology and Therapeutics 27: 628–635 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Verbeeck, R.; Tjandramaga, T.B.; Mullie, A.; Verbesselt, R. and De Schepper, P.J.: Effect of aluminium hydroxide on diflunisal absorption. British Journal of Clinical Pharmacology 7: 519–522 (1979a).

    Article  PubMed  CAS  Google Scholar 

  • Verbeeck, R.; Tjandramaga, T.B.; Mullie, A.; Verbesselt, R.; Verberckmoes, R. and De Schepper, P.J.: Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency. British Journal of Clinical Pharmacology 7: 273–282 (1979b).

    Article  PubMed  CAS  Google Scholar 

  • Verbeeck, R.K. and Wallace, S.M.: Does fenbufen have a large distribution volume or is it subject to extensive presystemic elimination? European Journal of Clinical Pharmacology 24: 137–138 (1983).

    Article  PubMed  CAS  Google Scholar 

  • Vert, P.; Bianchetti, G.; Marchai, R.; Monin, P. and Morselli, P.L.: Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus. European Journal of Clinical Pharmacology 18: 83–88 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Vesell, E.S.; Passananti, G.T. and Johnson, A.O.: Failure of indomethacin and warfarin to interact in normal human volunteers. Journal of Clinical Pharmacology 15: 486–495 (1975).

    PubMed  CAS  Google Scholar 

  • Wahlin-Boll, E.; Brantmark, B.; Hanson, A.; Melander, A. and Nilsson, C.: High-pressure liquid Chromatographic determination of acetylsalicylic acid, salicylic acid, diflunisal, indomethacin, indoprofen and indobufen. European Journal of Clinical Pharmacology 20: 375–378 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Wallace, S. and Brodie, M.J.: Decreased drug binding in serum from patients with chronic hepatic disease. European Journal of Clinical Pharmacology 9: 429–432 (1976).

    Article  CAS  Google Scholar 

  • Wallusch, W.W.; Nowak, H.; Leopold, G. and Netter, K.J.: Comparative bioavailability: Influence of various diets on the bioavailability of indomethacin. International Journal of Clinical Pharmacology and Biopharmacy 16: 40–44 (1978).

    PubMed  CAS  Google Scholar 

  • Wanwimolruk, S.; Birkett, D.J. and Brooks, P.M.: Protein binding of some non-steroidal anti-inflammatory drugs in rheumatoid arthritis. Clinical Pharmacokinetics 7: 85–92 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Weiner, M.; Chenkin, T. and Burns, J.J.: Observations on the metabolic transformation and effects of phenylbutazone in subjects with hepatic disease. American Journal of the Medical Sciences 228: 36–39 (1954).

    Article  PubMed  CAS  Google Scholar 

  • Whiting, B.; Lorenzi, M.; Robins, D.S. and Williams, R.: The influence of naproxen on glucose metabolism and tolbutamide pharmacologic effect. Clinical Pharmacology and Therapeutics 25: 253 (1979).

    Google Scholar 

  • Whitlam, J.B.; Brown, K.F.; Crooks, M.J. and Room, G.F.W.: Trans-synovial distribution of ibuprofen in arthritic patients. Clinical Pharmacology and Therapeutics 29: 487–492 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Whitlam, J.B. and Vine, J.H.: Quantitation of ibuprofen in biological fluids by gas chromatography-mass spectometry. Journal of Chromatography 181: 463–468 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Whitsett, T.L.; Barry, J.P; Czerwinski, A.W.; Hall, W.H. and Hampton, J.W.: Interaction of tolmetin and warfarin: A clinical investigation, in Ward (Ed.) Tolmetin a New Non-Steroidal Anti-Inflammatory Agent (Excerpta Medica, Princeton 1975).

    Google Scholar 

  • Wilkens, R.F. and Segre, E.J.: Combination therapy with naproxen and aspirin in rheumatoid arthritis. Arthritis and Rheumatism 19: 677–682 (1975).

    Article  Google Scholar 

  • Williams, R.L.; Upton, R.A.; Buskin, J.N. and Jones, R.M.: Ketoprofen-aspirin interactions. Clinical Pharmacology and Therapeutics 30: 226–231 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Willis, J.V.; Jack, D.B.; Kendall, M.J. and John, V.A.: The influence of food on the absorption of diclofenac as determined by the urinary excretion of the unchanged drug and its major metabolites during chronic administration. European Journal of Clinical Pharmacology 19: 39–44 (1981a).

    Article  PubMed  CAS  Google Scholar 

  • Willis, J.V. and Kendall, M.J.: Pharmacokinetic studies on diclofenac sodium in young and old volunteers. Scandinavian Journal of Rheumatology (Suppl. 22): 36–41 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Willis, J. V.; Kendall, M.J.; Flinn, R.M.; Thornhill, D.P. and Welling, P.G.: The pharmacokinetics of diclofenac sodium following intravenous and oral administration. European Journal of Clinical Pharmacology 16: 405–410 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Willis, J.V.; Kendall, M.J. and Jack, D.B.: A study of the effect of aspirin on the pharmacokinetics of oral and intravenous diclofenac sodium. European Journal of Clinical Pharmacology 18: 415–418 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Willis, J.V.; Kendall, M.J. and Jack, D.B.: The influence of food on the absorption of diclofenac after single and multiple oral doses. European Journal of Clinical Pharmacology 19: 33–37 (1981b).

    Article  PubMed  CAS  Google Scholar 

  • Wishinsky, H.; Glasser, E.J. and Perkal, S.: Protein interactions of sulfonylurea compounds. Diabetes 2 (Suppl.): 18–25 (1962).

    Google Scholar 

  • Wosilait, W.: Theoretical analysis of the binding of salicylate by human serum albumin. The relationship between free and bound drug and therapeutic levels. European Journal of Clinical Pharmacology 9: 285–290 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Yu, T.F.; Dayton, P.G. and Gutman, A.B.: Mutual suppression of the uricosuric effects of sulfinpyrazone and salicylate: A study in interactions between drug. Journal of Clinical Investigation 42: 1330–1339 (1963).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, University of Saskatchewan, Saskatoon, Saskatchewan, S7N 0W0, Canada

    Roger K. Verbeeck, Jim L. Blackburn & Gordon R. Loewen

Authors
  1. Roger K. Verbeeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jim L. Blackburn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gordon R. Loewen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verbeeck, R.K., Blackburn, J.L. & Loewen, G.R. Clinical Pharmacokinetics of Non-steroidal Anti-inflammatory Drugs. Clin Pharmacokinet 8, 297–331 (1983). https://doi.org/10.2165/00003088-198308040-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198308040-00003

Keywords

Search

Navigation